Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies [Phase 1]
A Phase 1 safety study of Clostridium novyi-NT spores for solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer [Phase 1]
This clinical trial update reports completion of a Phase 1 pivotal bioequivalence study of the liposomal doxorubicin formulation DOXIL/CAELY…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the combination of trastuzumab (Herceptin) and tanespimycin in patients with solid tumors and HER2-pos…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 dose-escalation trial assesses ombrabulin in combination with paclitaxel and carboplatin in patients with advanced solid tumors…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors [Phase 1]
A Phase 1 clinical trial assessing the combination of everolimus and bevacizumab in pediatric patients with recurrent solid tumors and CNS m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) [Phase 1, Phase 2]
This clinical trial update reports termination of a Phase 1/2 study of Epofolate (BMS-753493) in subjects with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) [Phase 1, Phase 2]
Phase 1/2 study of Epofolate (BMS-753493) in advanced solid tumors was terminated, with the trial status showing TERMINATED.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part) [Phase 2]
Phase I/II trial update from Japan evaluating the dabrafenib and trametinib combination in patients with BRAF V600 mutation-positive advance…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of Trebananib (AMG 386) in adult Japanese participants with advanced sol…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 1]
Phase 1 study of Vinorelbine Liposome Injection for advanced solid tumors, Hodgkin lymphoma, and Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED) [Phase 1]
A completed Phase 1 safety study of ridaforolimus (MK-8669) in patients with advanced, refractory or recurrent malignancies, including lymph…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma [Phase 1]
Global Phase 1 study to assess the safety and tolerability of AZD1208 in patients with advanced solid tumors and malignant lymphoma; the stu…
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors [Phase 1]
Phase 1 study evaluating drug-drug interaction between RO5503781 and posaconazole, oral formulation bioavailability of RO5503781, and the fo…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors [Phase 1, Phase 2]
Open-label Phase 1/2 trial evaluating YM155 in combination with docetaxel in advanced hormone-refractory prostate cancer and other solid tum…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
This clinical trial update reports on the tolerance of Nivestim (filgrastim) in patients treated with highly toxic chemotherapeutic regimens…
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours [Phase 1]
A completed Phase 1 trial assessing pantoprazole in combination with doxorubicin in patients with advanced solid tumors, including an extens…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors [Phase 1]
Phase 1 clinical trial update on tivantinib for pediatric relapsed/refractory solid tumors. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating whether itraconazole and fluconazole alter the pharmacokinetics of selumetinib in healthy male volunteers. The tria…
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects [Phase 1]
Phase 1 pharmacokinetics and safety study evaluating selumetinib in renal-impaired and healthy subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma [Phase 1]
Phase I pharmacology study evaluating camptothecin-20-O-propionate hydrate (CZ48) in patients with advanced solid tumors or lymphomas; the t…
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies [Phase 1]
A Phase 1 trial evaluating pazopanib in combination with carboplatin for advanced metastatic solid malignancies; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies [Phase 1]
This clinical trial update notes the completion of a Phase 1 safety study investigating cetuximab plus dasatinib in patients with advanced s…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors. [Phase 1]
This update reports the completion of a Phase 1 study evaluating NM-3, administered orally, in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 trial of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of UCN-01 with prednisone in adults with lymphoma or solid tumors has completed.